XDH and metabolic syndrome: Thus, it has been shown that plasma XOR activity is independently associated not only with hyperuricemia but also with obesity, hepatic dysfunction, smoking, dyslipidemia, and insulin resistance in the general population, suggesting that plasma XOR activity could be a new metabolic biomarker [53].